JP
Joseph M Patti
CEODirector

Joseph M Patti insider trades: Biota Pharmaceuticals (BOTA) stock buys and sales

CEO, Biota Pharmaceuticals Last trade Sep 25, 2015 38 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2006
4
Companies
last trade 2015

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Joseph reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 25, 2015BOTA↑ Buy$9K
Mar 27, 2015BOTA↑ Buy$46K
Jun 30, 2014BOTA↑ Buy$29K
Jun 27, 2014BOTA↑ Buy$12K
Jun 27, 2014BOTA↑ Buy$2K
Jun 11, 2014BOTA↑ Buy$38K
Nov 4, 2011INHX↓ Sell$1.6M
Nov 14, 2008INHX↑ Buy$4K
Jan 13, 2006INHX↓ Sell$316K
Jan 12, 2006INHX↓ Sell$383K
Jan 10, 2006INHX↓ Sell$249K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Joseph M Patti's insider trades

Joseph M Patti is CEO at Biota Pharmaceuticals (BOTA). Since Jan 10, 2006, Joseph has reported 7 open-market purchases worth $140K and 4 sales worth $2.6M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (24 filings), shares returned to the company (3 filings), option exercises (3 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BOTA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.